As noted earlier today, Chinese-based prospect Ning Guangyou tested positive for trace amounts of clenbuterol in an out-of-competition drug test administered by USADA, however due to the uniqueness of his test results, he won’t be facing a suspension.
For more information on the unique nature of hie test results and thr banned substance he popped for, read the detailed statement that USADA issued earlier today by clicking here<.
While he won’t be facing a suspension as a result of the positive drug test, UFC announced via their official website that his next scheduled fight against Marlon Vera, which was set to go down on the undercard of next Saturday’s UFC 202: Diaz vs. McGregor 2 pay-per-view, has been movved to the UFC Fight Night: Condit vs. Maia event on FOX Sports 1 instead.
Below is the complete statement that the UFC released on Tuesday afternoon:
UFC STATEMEMT ON NING GUANGYOU
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA), the independent administrator of the UFC Anti-Doping Policy, has completed an investigation into the circumstances of a positive test for Ning Guangyou, resulting in a no-fault sanction with no period of ineligibility.
In late July, UFC was made aware of USADA’s investigation into the source of the prohibited substance clenbuterol in an out of competition sample collected from Ning Guangyou. Given it was initially unclear as to the timing of the resolution of the investigation, UFC made the decision to move Guangyou’s scheduled bout against Marlon Vera on August 20, 2016 at UFC 202 to UFC Fight Night: Maia vs. Condit in Vancouver, BC on August 27, 2016.
Details of the USADA investigation into Guangyou’s positive test are available at http://ufc.usada.org/ning-guangyou-receives-finding-no-fault/